With box warnings

Without box warnings

Branded

Generic

3 results

mavyret
(Glecaprevir and Pibrentasvir)
AbbVie Inc.
Usage: MAVYRET is indicated for treating chronic hepatitis C virus (HCV) genotypes 1-6 in patients aged 3 years and older, with or without compensated cirrhosis. It is also approved for HCV genotype 1 patients who have previously received specific antiviral treatments.
ribavirin
(Ribavirin)
Aurobindo Pharma Limited
Usage: Ribavirin capsules, in combination with interferon alfa-2b (pegylated and nonpegylated), are indicated for treating Chronic Hepatitis C (CHC) in patients aged 3 years and older with compensated liver disease. Combination with PegIntron is preferred for better response rates. Long-term treatment safety and efficacy beyond one year are not established.
vosevi
(SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR)
Gilead Sciences, Inc.
Usage: VOSEVI is indicated for treating adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have specific genotypes and have previously been treated with certain HCV regimens, particularly those including an NS5A inhibitor.

Medications for Hepatitis C Chronic

mavyret